A research team led by Sheri Holmen, Ph.D., investigator at Huntsman Cancer Institute and professor in the Department of ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.

Objectives The administration of androgen deprivation therapy (ADT) to patients with metastatic prostate cancer might be associated with some adverse effects such as anaemia; however, few studies have ...

No writing assistance was utilized in the production of this manuscript. Sequential therapy refers to treatment with drug regimens administered one after another. Combination therapy refers to ...

The sequential treatment with THIO followed by PD-(L)1 inhibitors resulted in profound and persistent tumor regression in advanced, in vivo cancer models by induction of cancer type–specific ...

The trial used residual DNA from cancer cells that can find its way into a patient's bloodstream to identify when patients were beginning to resist the standard endocrine treatment, and were ...

What makes cancer cells weak A new approach in the fight against therapy resistance Date: February 25, 2025 Source: University of Graz Summary: One particular challenge in the treatment of cancer ...

In an interview with Targeted Oncology, David W. Dougherty, MD, discussed how the COVID-19 pandemic has changed the cancer care space. Read More Clinical Treatment Act Aims to Improve Survival, Close ...

MIBC is a serious form of bladder cancer that has spread into the muscle layer of the bladder wall. The standard treatment is a radical cystectomy, which involves surgically removing the entire ...

When you have cancer, though, some cells start to divide way too fast. That's where radiation therapy can help. It uses high-energy particles to make tiny breaks in the DNA of cancer cells to ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for CAR T-cell therapy, with her husband George. At 36 years old Emma Holden has run ...